The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
head and neck cancer
The Research Round Up podcast series continues with 2 new expert-led podcasts on research highlights from the 2016 ASCO Annual Meeting.
First in our summer Research Round Up podcast series, Charles Loprinzi, MD, and Ezra Cohen, MD, unpack some of science highlights from the 2015 ASCO Annual Meeting.
Is More Extensive Surgery Better for Early-Stage Oral Cancer? – Research from the 2015 ASCO Annual Meeting
Doctors worldwide have struggled with this question for decades. A new study presented today at the 2015 ASCO Annual Meeting provides clarification on whether lymph nodes should be removed before or after cancer has been detected in the nodes of people with early-stage oral cancer.
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers.
The side effects of throat cancer treatment left Doug Bradley nearly deaf and unable to eat the foods he loves. And yet, he still has no regrets.
New Strategies to Improve Quality of Life for Patients, Survivors, and Caregivers From the 2014 ASCO Annual Meeting
Researchers are continuing to find new ways to reduce the side effects of treatment and improve quality of life. Get highlights of five studies presented today at the ASCO Annual Meeting.
Dr. Jonas de Souza describes the progress that’s been made in head and neck cancer research. Listen to these highlights from the 2014 Multidisciplinary Head and Neck Cancers Symposium.